Mental Health

Research, services and policy on mental health, stress, depression and anxiety, and workplace and school wellbeing.

Latest Mental Health stories

Scientists Discover a Brain Signal Linked to Ketamine’s Antidepressant Effects
health

Scientists Discover a Brain Signal Linked to Ketamine’s Antidepressant Effects

The findings could help researchers better understand how people with depression respond to treatment. Ketamine can act quickly against depression that has not improved with other treatments. In a study of U.S. veterans over 55, researchers found that the brain’s response continued to change over the following week, with one pattern of activity linked to [...]

Scitechdaily•
Sep 21, 2026

Listed cancer treatment developer Prescient raising to fund trials

Prescient Therapeutics is working on a new cancer therapy it claims has shown promising signs in early trials focused on blood cancers.

Afr•
Sep 21, 2026
Evinco Therapeutics and ARMI announce research collaboration to advance a novel NK-EV therapy for Alzheimer’s disease
health

Evinco Therapeutics and ARMI announce research collaboration to advance a novel NK-EV therapy for Alzheimer’s disease

Collaboration will generate human iPSC-derived brain cell models to investigate the effects of Evinco’s NK-EV platform on neuroinflammation Melbourne

The National Tribune•
Sep 21, 2026

Evinco Therapeutics and ARMI announce research collaboration to advance a novel NK-EV therapy for Alzheimer’s disease – News Hub - Medianet News Hub

Evinco Therapeutics and ARMI announce research collaboration to advance a novel NK-EV therapy for Alzheimer’s disease – News Hub Medianet News Hub

Google News•
Sep 21, 2026

Evinco, ARMI Partner on NK-EV Therapy for Alzheimer's - Mirage News

Evinco, ARMI Partner on NK-EV Therapy for Alzheimer's Mirage News

Google News•
Sep 21, 2026

Evinco Therapeutics and ARMI announce research collaboration to advance a novel NK-EV therapy for Alzheimer’s disease

Collaboration will generate human iPSC-derived brain cell models to investigate the effects of Evinco’s NK-EV platform on neuroinflammation Melbourne, Australia, 21 September 2026 – Evinco Therapeutics Pty Ltd (“Evinco” or “Company”) and the Australian Regenerative Medicine Institute (ARMI) today announced a research collaboration to advance a novel natural killer cell-derived extracellular vesicle (NK-EV) therapy for ... Continued

News Hub - Medianet News Hub Archive•
Sep 21, 2026
Abbisko's Lavengratinib Shows Early Height-Growth Benefit In Phase II Achondroplasia Study
business

Abbisko's Lavengratinib Shows Early Height-Growth Benefit In Phase II Achondroplasia Study

Abbisko Therapeutics Co., Ltd. (2256.HK) said preliminary results from a Phase II study of lavengratinib (ABSK061) showed improved growth rates in children with achondroplasia, while the investigational therapy continued to demonstrate a favorable safety profile.

Rttnews•
Sep 21, 2026
Choate workers’ union files lawsuit to block state from gutting mental health facility
health

Choate workers’ union files lawsuit to block state from gutting mental health facility

ANNA — The labor union representing hundreds of employees at Choate Mental Health and Developmental Center has filed a lawsuit challenging the state’s planned downsizing of the facility, arguing Gov. JB Pritzker’s administration failed to follow state laws governing reductions in healthcare services, the closure of state facilities and the preservation of psychiatric beds. ...

The Daily Egyptian•
Sep 21, 2026
New Treatment Cuts “Bad” Cholesterol in Half for a Full Year
health

New Treatment Cuts “Bad” Cholesterol in Half for a Full Year

A single infusion of an experimental CRISPR-Cas9 therapy was reported to safely lower LDL cholesterol by 52.5% and triglycerides by 47.8%, as measured 12 months after treatment. What if one infusion could keep cholesterol down for a year? An experimental gene-editing treatment called CTX310 has shown early promise in people whose cholesterol and other blood [...]

Scitechdaily•
Sep 21, 2026
Base Editing Corrected TFG Mutation in Motor Neuron Disease
science

Base Editing Corrected TFG Mutation in Motor Neuron Disease

Adenine base editing corrected the TFG mutation in motor neuron disease models. The therapy improved motor performance and extended survival in mice. These results highlight a promising new therapeutic approach.

Technology Networks•
Sep 21, 2026
Queen’s team playing key role in first all-island mental health research network
health

Queen’s team playing key role in first all-island mental health research network

Researchers from Queen’s University Belfast are playing important roles in Ireland’s first all-island mental health research initiative which has been set up to help combat mental ill health in a more coordinated way across Ireland.

Queen's University Belfast•
Sep 21, 2026

AI is the biggest challenge facing young people’s mental health

AI is the biggest challenge facing young people’s mental health

The Times•
Sep 20, 2026

Approach to AI in schools ‘squanders benefits and risks mental harm’ - The Times

Approach to AI in schools ‘squanders benefits and risks mental harm’ The Times AI poses ‘biggest challenge’ to young people’s mental health, expert warns The Independent ‘I’m Listening Hard’: Teens Increasingly Turn to AI Chatbots for Mental Health Support The Good Men Project What doctors need to know about AI psychosis InSight+ Four signs using AI might be affecting your mental health The Star

Google News•
Sep 20, 2026
The RV Book Fair 2026 – Sarah Deschamps
health

The RV Book Fair 2026 – Sarah Deschamps

Your books are deeply personal and explore resilience, motherhood, medical trauma, and mental health. What gave you the courage to share such intimate parts of your family’s journey with readers? People who experience this kind of trauma don’t tell their stories. We keep them to ourselves. We hide. I titled my book, “I Couldn’t Tell [...] The post The RV Book Fair 2026 – Sarah Deschamps appeared first on Brand Education .

Brand Education•
Sep 20, 2026
Seven in ten GPs believe adult ADHD is over-diagnosed and some have NEVER known a private provider reject a diagnosis
health

Seven in ten GPs believe adult ADHD is over-diagnosed and some have NEVER known a private provider reject a diagnosis

Doctors raised concerns about 'superficial' assessments and warned that trauma and other mental health problems could be overlooked.

Mail Online•
Sep 20, 2026
Psilocybin and standard antidepressants both shift the brain away from negative biases
general

Psilocybin and standard antidepressants both shift the brain away from negative biases

A new study reveals that psilocybin and standard antidepressants both reduce the brain's tendency to misinterpret facial expressions as negative. The research suggests these two distinct treatments share a common cognitive effect in the fight against depression.

Psypost - Psychology News•
Sep 20, 2026
‘It’s a form of therapy’: Quebec line dancing school sees boom in attendance
sports

‘It’s a form of therapy’: Quebec line dancing school sees boom in attendance

A country line dancing school in Saint-Lazare, Que., has recently experienced an exponential increase in attendance. As a result, it’s had to add more cla...

Yahoo! News•
Sep 20, 2026
‘It’s a form of therapy’: Quebec line dancing school sees boom in attendance
sports

‘It’s a form of therapy’: Quebec line dancing school sees boom in attendance

A country line dancing school in Saint-Lazare, Que., has recently experienced an exponential increase in attendance. As a result, it’s had to add more classes, reaching 10 different locations in the greater Montreal area.

Canadian Asian News•
Sep 20, 2026
NorahLux Launches Red Light Therapy Research Hub With Access to 10,000+ Photobiomodulation Studies
science

NorahLux Launches Red Light Therapy Research Hub With Access to 10,000+ Photobiomodulation Studies

Interactive research explorer helps users search scientific literature by condition, study type, light source and other criteria DEURNE, Netherlands, Sept. 19, 2026 (GLOBE NEWSWIRE) — NorahLux has launched the Red...

Nynewscast•
Sep 20, 2026
Esketamine-induced dissociation is tied to better outcomes in treatment-resistant depression
health

Esketamine-induced dissociation is tied to better outcomes in treatment-resistant depression

Patients with treatment-resistant depression who experienced feelings of unreality during subcutaneous esketamine therapy were more likely to see their depression symptoms improve, suggesting dissociation may be tied to the drug's effectiveness rather than just a side effect.

Psypost - Psychology News•
Sep 20, 2026

How Info60 covers this topic

Each story below is a short excerpt from reporting by an established publisher, shown in the publisher's own words. We credit the publisher and link to the original article. Stories are matched to this topic by keyword and shown newest first.

Related topics